Nordic News, Business and Life in Asia
The Danish pharmaceutical giant Novo Nordisk has reported encouraging results from a new diabetes and weight loss drug developed with a Chinese partner, Fierce Biotech reports. The candidate, known as …
Novo Nordisk tests China-developed drug for obesity and diabetes while competition is growing Read More
Novo Nordisk will lose patent protection for its blockbuster drug Ozempic in several major markets from Saturday. The patent expiry opens the door for other manufacturers to produce cheaper generic …
Novo Nordisk will lose patent protection on Saturday Read More
A Chinese biotechnology company, Shanghai Shiling Pharmaceutical, plans to complete clinical trials by 2028 for a weight-loss nasal spray that uses semaglutide, the same active ingredient as Danish drugmaker Novo Nordisk’s …
Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China Read More
Novo Nordisk said China’s Supreme People’s Court has upheld the validity of its semaglutide compound patent, according to a company statement issued on Saturday. China’s Supreme People’s Court thereby confirmed …
Novo Nordisk says China court upholds its semaglutide patent Read More
Danish pharmaceutical company Novo Nordisk has officially launched its once-weekly injectable weight management drug, Wegovy® (semaglutide 2.4mg), in Singapore. The treatment received regulatory approval from Singapore’s Health Sciences Authority on …
Novo Nordisk launches Wegovy in Singapore for weight management Read More
Danish pharmaceutical giant Novo Nordisk is striving to increase capacity for its blockbuster medications, Ozempic and Wegovy. To ramp up production, Novo Nordisk will focus on hiring outside of Denmark, …
Novo Nordisk expands footprint in China with recruitment shift Read More
Novo Nordisk has officially launched its weight loss medication Wegovy in China. This move opens access to over 500 million potential candidates for treatment by 2045. Regulatory approval and market …
Novo Nordisk launches Wegovy in China Read More
Novo Nordisk, the Danish pharmaceutical giant renowned for its diabetes and weight-loss medications, including the blockbuster drugs Ozempic and Wegovy, announced impressive third-quarter earnings despite challenges with production constraints. Novo …
Novo Nordisk reports strong profits despite production constraints Read More
Just as Novo Nordisk’s weight loss drug Wegovy has been allowed on the Chinese market, the company’s Chinese rivals Innovent Biologics and Eli Lilly have published news about their own …
New Chinese drug can challenge Novo Nordisk’s Wegovy in China Read More
The popular weight loss medicin Wegovy by the Danish phamaceutical firm Novo Nordisk has been approved for consumers in China. This has been confirmed by an employee at the company. …
Wegovy approved in China Read More